Recent news on Ropivacaine

KJ Jeray, AE Williams, SJ Morgan, SL Tanner, WR Smith, and JS ...  -  May 1, 2007
Journal of Bone and Joint Surgery (subscription)We did not administer continuous analgesia at the second operative site, nor did we use a bolus 30 mL of ropivacaine at the iliac crest graft site prior to

Ion channel specialist receives innovation award  -  May 17, 2007
LabTechnologist.com,One example is AstraZeneca's and Abraxis BioScience's marketed pain medication, Naropin (ropivacaine), is a calcium channel blocker that carries a FDA

Continuous Infusion of Local Anesthetic at Iliac Crest Bone-Graft ...  -  May 1, 2007
Journal of Bone and Joint Surgery (subscription)A continuous infusion of 0.2% ropivacaine at a rate of 5 mL/hr over forty-eight hours was successfully used in this surgical context 1 .

FDA Safety Changes: Keppra, Naropin, Rebetol  -  Dec 22, 2006
Medscape (subscription)On August 8, the FDA approved safety label changes for ropivacaine HCl injection (Naropin, made by Abraxis BioScience, Inc) to warn of the rare risk for

FDA Safety Changes: Keppra, Naropin, Rebetol  -  Dec 22, 2006
Medscape (subscription)On August 8, the FDA approved safety label changes for ropivacaine HCl injection (Naropin, made by Abraxis BioScience, Inc) to warn of the rare risk for

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional